Cellular Dynamics provides drug screening and toxicity testing products based on breakthrough induced pluripotent stem (iPS) cell technology. The Company's whole product solution also includes GLP and non-GLP hERG screening services based on the HEK293 hERG cell line.
iPS Cells Deliver: Using CDI's patented iPS cell technology, human skin cells can be reprogrammed into stem cells, which can then be differentiated into any cell type.
